Moffitt Cancer Center published a multicenter real-world study evaluating bispecific antibodies in 122 patients with primary or secondary plasma cell leukemia, showing talquetamab had encouraging response and survival outcomes.
Public source
Publisher name
Public post
Pleased to share this multicenter real-world study evaluating bispecific antibodies in 122 patients with primary or secondary plasma cell leukemia—a population largely e…
Company
Moffitt Cancer Center
To contribute to the prevention and cure of cancer
- Industry
- Hospitals and Health Care
- Location
- Tampa, US
- Company size
- 5,001–10,000 employees
About Moffitt Cancer Center
At Moffitt Cancer Center, we come face-to-face with cancer every day, but we also see courage. And it inspires us to be the safest and best place for cancer care – to bring greater hope to every patient we serve. It’s why we’ve been continually named One of the Top Places to Work in the Tampa Bay Area. As the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, Moffitt employs some of the best and brightest minds from around the world. Moffitt is the top cancer hospital in Florida according to U.S. News & World Report and has been nationally ranked since 1999. Because working at Moffitt is both a career and a mission: to contribute to the prevention and cure of cancer. Join a dedicated, diverse and inclusive team of over 10,000 to be a part of the Courageous future we envision.
See moreLatest activity
Latest activity from Moffitt Cancer Center
21 signals
Research & Knowledge
Moffitt Cancer Center published a new paper led by Leonid Kostrykin and Beatriz Serrano-Solano PhD discussing bioimage analysis and management software tools for the Galaxy Project.
Presence & Recognition
Moffitt Cancer Center remains Florida's longest-established National Cancer Institute-designated Comprehensive Cancer Center more than two decades after its designation in 2001.
Research & Knowledge
Moffitt Cancer Center published a study in Nature Chemical Biology revealing that the sugars on tumor-fighting T cells can influence whether they survive inside a tumor.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
University of Colorado Anschutz Cancer Center
University of Colorado Anschutz Cancer Center published a study by Ajay Major, MD, MBA, and Vincenzo Pizzuti, MD, MS, showing the results of their survey into how patients feel following CAR T-cell therapy.
Research & Knowledge
City of Hope
City of Hope published a paper on molecular characterization of appendiceal cancer, analyzing 861 primary and metastatic cases across seven oncogenic pathways.
Research & Knowledge
UT MD Anderson
UT MD Anderson researchers led by Michael Andreeff, M.D., Ph.D., and Yuki Nishida, M.D., Ph.D., showed preclinical findings in a study that demonstrated strong anti-cancer activity from a first-in-class therapy to target MYC, a protein involved in about 70% of cancers.
Research & Knowledge
The London Clinic
The London Clinic published a study showing that tarlatamab combined with durvalumab showed positive results in small-cell lung cancer.
Research & Knowledge
UPMC Hillman Cancer Center